ECSIT Is a Critical Factor for Controlling Intestinal Homeostasis and Tumorigenesis through Regulating the Translation of YAP Protein.

The intestinal epithelium is the fastest renewing tissue in mammals and its regenerative process must be tightly controlled to minimize the risk of dysfunction and tumorigenesis. The orderly expression and activation of Yes-associated protein (YAP) are the key steps in driving intestinal regeneration and crucial for intestinal homeostasis. However, the regulatory mechanisms controlling this process remain largely unknown. Here, it is discovered that evolutionarily conserved signaling intermediate in Toll pathways (ECSIT), a multi-functional protein, is enriched along the crypt-villus axis. Intestinal cell-specific ablation of ECSIT results in the dysregulation of intestinal differentiation unexpectedly accompanied with enhanced YAP protein dependent on translation, thus transforming intestinal cells to early proliferative stem "-like" cells and augmenting intestinal tumorigenesis. Loss of ECSIT leads to metabolic reprogramming in favor of amino acid-based metabolism, which results in demethylation of genes encoding the eukaryotic initiation factor 4F pathway and their increased expression that further promotes YAP translation initiation culminating in intestinal homeostasis imbalance and tumorigenesis. It is also shown that the expression of ECSIT is positively correlated with the survival of patients with colorectal cancer. Together, these results demonstrate the important role of ECSIT in regulating YAP protein translation to control intestinal homeostasis and tumorigenesis.

Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease.

BACKGROUND: Neuroinflammation has been widely accepted as a cause of the degenerative process. Increasing interest has been devoted to developing intervening therapeutics for preventing neuroinflammation in Parkinson's disease (PD). It is well known that virus infections, including DNA viruses, are associated with an increased risk of PD. In addition, damaged or dying dopaminergic neurons can release dsDNA during PD progression. However, the role of cGAS, a cytosolic dsDNA sensor, in PD progression remains unclear. METHODS: Adult male wild-type mice and age-matched male cGAS knockout (cGas-/- ) mice were treated with MPTP to induce neurotoxic PD model, and then behavioral tests, immunohistochemistry, and ELISA were conducted to compare disease phenotype. Chimeric mice were reconstituted to explore the effects of cGAS deficiency in peripheral immune cells or CNS resident cells on MPTP-induced toxicity. RNA sequencing was used to dissect the mechanistic role of microglial cGAS in MPTP-induced toxicity. cGAS inhibitor administration was conducted to study whether GAS may serve as a therapeutic target. RESULTS: We observed that the cGAS-STING pathway was activated during neuroinflammation in MPTP mouse models of PD. cGAS deficiency in microglia, but not peripheral immune cells, controlled neuroinflammation and neurotoxicity induced by MPTP. Mechanistically, microglial cGAS ablation alleviated the neuronal dysfunction and inflammatory response in astrocytes and microglia by inhibiting antiviral inflammatory signaling. Additionally, the administration of cGAS inhibitors conferred the mice neuroprotection during MPTP exposure. CONCLUSIONS: Collectively, these findings demonstrate microglial cGAS promote neuroinflammation and neurodegeneration during the progression of MPTP-induced PD mouse models and suggest cGAS may serve as a therapeutic target for PD patients. LIMITATIONS OF THE STUDY: Although we demonstrated that cGAS promotes the progression of MPTP-induced PD, this study has limitations. We identified that cGAS in microglia accelerate disease progression of PD by using bone marrow chimeric experiments and analyzing cGAS expression in CNS cells, but evidence would be more straightforward if conditional knockout mice were used. This study contributed to the knowledge of the role of the cGAS pathway in PD pathogenesis; nevertheless, trying more PD animal models in the future will help us to understand the disease progression deeper and explore possible treatments.

[Washing copper (II)-contaminated soil using surfactant solutions].

The batch equilibrium washing of copper (II) in the soil matrix by anionic surfactant, sodium dodecylbenzyl sulfonate (SDBS), nonionic surfactant, octylphenoxypolyethoxyethanol (TX100), and their mixture (SDBS-TX100), was studied and compared. The influences of surfactant concentrations, washing time, pH values of solutions, ratios of soil to water and inorganic salts on washing efficiency were investigated. It was shown that the washing efficiency differed with the kinds of surfactants. Given the initial surfactant concentrations, the washing of copper (II) by single SDBS was greater than those by single TX100 and the mixed SDBS-TX100. The washing efficiency by 6 000 mg x L(-1) of SDBS was up to 46.3%, which was 5.8, 10.8, 10.8 and 19.3 times as those by SDBS-TX100 (3:1), SDBS-TX100 (1:1), SDBS-TX100 (1:3) and single TX100 respectively. When the ratio of soil to water was 1 to 10 and washing time reached 24 h, the washing efficiency achieved the maximum. pH values of solutions had obvious effect on the washing of copper (II). The washing efficiency of copper decreased sharply with the increase of pH. At the high acidity (pH = 1.50), the washing efficiency of copper (II) was up to 95%. The smaller the ratios of soil to water were, the higher the washing efficiencies would be. The existence of inorganic salts with the certain concentrations, such as Na+, Ca2+ and Mg2+, could not influence the washing capacity of surfactants, but the excessive Mg2+ (more than 500 mg x L(-1)) could resulted in the precipitation of SDBS. The results will make an implication for surfactant-enhanced remediation of soils contaminated with heavy metals.